Mankind Pharma Limited (MANKIND) secures exclusive in-licensing agreement for Insulin Degludec and Insulin Degludec + Aspart for India, expanding its diabete.
Strides Pharma Science Limited (STAR) announced the positive USFDA Establishment Inspection Report for its Bengaluru facility, reinforcing its commitment to.
Fabtech Technologies Limited (FABTECH) secures AED 9.92 million turnkey project in UAE, expanding its critical infrastructure platform.
Ind-Swift Laboratories Limited (INDSWFTLAB) to upgrade Jammu facility to EUGMP and PICS standards, targeting additional revenue of ₹100 crores from 2029-30.
Alivus Life Sciences Limited (ALIVUS) acquires 76% stake in IQGenX for INR 91.2 million, expanding its advanced formulation development capabilities.
NGL Fine-Chem Limited (NGLFINE) reports Q1FY27 results with sustained demand, profitability growth, and strategic capex plans.
Rubicon Research Limited (RUBICON) stock moves up 10% intraday, breaking out above its 6-month resistance trendline at ₹1646.
Lupin Limited (LUPIN) receives U.S. FDA approval for Pitolisant Tablets, marking a significant milestone in its pharmaceutical portfolio.
Dishman Carbogen Amcis Limited (DCAL) reports Q1FY27 results with net revenue dipping 4.29%, driven by CDMO segment decline.
Rubicon Research Limited (NSE: RUBICON) stock breaks out, moving up 6% intraday to ₹1723.7, clearing its 6M resistance trendline.